⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EYPT News
EyePoint Pharmaceuticals, Inc. Common Stock
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
globenewswire.com
EYPT
EyePoint Announces Participation at Upcoming Investor Conferences
globenewswire.com
EYPT
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
globenewswire.com
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
EyePoint Announces Pricing of Public Offering
globenewswire.com
EYPT
EyePoint Announces Proposed Public Offering of Common Stock
globenewswire.com
EYPT
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
globenewswire.com
EYPT